Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 4.8 (4.8, 4.8) N/A 18,441 28.5
Puerto Rico 6 *** 1.8 (1.6, 2.0) N/A 81 20.8
District of Columbia 6 *** 3.4 (2.8, 4.1) 50 (38, 50) 23 27.2
Colorado 6 *** 3.9 (3.7, 4.2) 49 (41, 50) 239 27.8
Nevada 6 *** 4.0 (3.6, 4.3) 48 (37, 50) 107 26.5
Maryland 6 *** 4.0 (3.8, 4.2) 47 (41, 50) 278 25.8
Virginia 6 *** 4.0 (3.8, 4.2) 46 (41, 50) 393 25.9
Oregon 6 *** 4.2 (3.9, 4.5) 45 (34, 49) 216 27.1
Florida 6 *** 4.2 (4.1, 4.3) 44 (39, 47) 1,201 28.8
Hawaii 3 *** 4.2 (3.8, 4.7) 43 (25, 50) 77 32.7
Utah 3 *** 4.3 (4.0, 4.7) 42 (25, 49) 116 30.5
Delaware 6 *** 4.4 (3.8, 4.9) 41 (19, 50) 54 26.2
Arizona 6 *** 4.4 (4.2, 4.6) 40 (30, 46) 368 27.5
Alabama 6 *** 4.4 (4.2, 4.7) 39 (26, 46) 266 24.8
California 3 *** 4.4 (4.3, 4.5) 38 (34, 43) 1,897 29.9
New York 3 *** 4.6 (4.4, 4.7) 37 (27, 42) 1,081 27.2
Washington 5 *** 4.6 (4.4, 4.8) 36 (24, 42) 392 30.1
New Jersey 3 *** 4.6 (4.4, 4.8) 35 (24, 42) 502 28.2
New Hampshire 6 *** 4.6 (4.2, 5.1) 34 (14, 47) 83 29.9
North Carolina 6 *** 4.7 (4.5, 4.8) 33 (23, 40) 572 27.2
Michigan 5 *** 4.7 (4.5, 4.8) 32 (23, 40) 585 28.8
Idaho 3 *** 4.7 (4.3, 5.2) 31 (12, 47) 90 28.4
Pennsylvania 6 *** 4.7 (4.6, 4.9) 30 (23, 38) 793 27.6
Vermont 6 *** 4.7 (4.1, 5.5) 29 (5, 49) 41 32.3
Connecticut 3 *** 4.8 (4.5, 5.1) 28 (16, 41) 216 30.1
South Carolina 6 *** 4.8 (4.6, 5.1) 27 (17, 38) 302 27.3
Wyoming 6 *** 4.9 (4.2, 5.7) 26 (3, 49) 34 35.3
Montana 6 *** 4.9 (4.4, 5.5) 25 (5, 44) 68 29.8
Maine 6 *** 4.9 (4.5, 5.4) 24 (6, 42) 97 29.8
Rhode Island 6 *** 5.0 (4.5, 5.6) 23 (4, 44) 66 31.3
Tennessee 6 *** 5.1 (4.8, 5.3) 22 (12, 31) 414 26.7
North Dakota 6 *** 5.1 (4.4, 5.9) 21 (2, 45) 44 29.7
Georgia 3 *** 5.1 (5.0, 5.3) 20 (11, 28) 572 29.6
Kansas 6 *** 5.1 (4.8, 5.5) 19 (6, 34) 175 26.9
New Mexico 3 *** 5.2 (4.8, 5.6) 18 (5, 36) 132 34.6
Ohio 6 *** 5.2 (5.0, 5.4) 17 (9, 26) 761 30.4
Minnesota 6 *** 5.3 (5.0, 5.5) 16 (6, 27) 345 30.5
South Dakota 6 *** 5.3 (4.7, 6.0) 15 (1, 41) 56 31.4
Illinois 6 *** 5.3 (5.2, 5.5) 14 (7, 23) 800 29.6
Texas 6 *** 5.4 (5.3, 5.5) 13 (7, 19) 1,525 28.1
Wisconsin 6 *** 5.4 (5.2, 5.7) 12 (4, 23) 394 29.7
Nebraska 6 *** 5.5 (5.0, 5.9) 11 (1, 28) 123 31.1
Missouri 6 *** 5.5 (5.3, 5.7) 10 (4, 22) 415 29.3
Indiana 6 *** 5.6 (5.3, 5.8) 9 (3, 20) 430 29.3
Alaska 6 *** 5.6 (4.8, 6.5) 8 (1, 40) 40 29.5
Arkansas 6 *** 5.7 (5.3, 6.0) 7 (1, 20) 207 27.3
Oklahoma 6 *** 5.7 (5.4, 6.0) 6 (1, 19) 263 28.7
Mississippi 6 *** 5.7 (5.4, 6.1) 5 (1, 20) 202 26.2
West Virginia 6 *** 5.9 (5.5, 6.4) 4 (1, 18) 149 29.3
Kentucky 3 *** 5.9 (5.6, 6.2) 3 (1, 13) 320 28.7
Louisiana 3 *** 6.1 (5.8, 6.4) 2 (1, 8) 329 27.8
Iowa 3 *** 6.2 (5.8, 6.6) 1 (1, 8) 243 32.7
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/01/2022 4:29 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Massachusetts

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top